The Future of Biomarker-Based Therapy for Mental Disorder Care

The rising prevalence of mental health disorders, particularly PTSD, presents challenges for existing treatments. Current therapies, while effective for many, yield small effect sizes compared to standard treatments. The incorporation of neurological biomarkers could revolutionize mental disorder care. Traditional biomarkers depend on invasive procedures and can't access brain activity due to the blood-brain barrier. However, the fusion of EEG and fMRI technologies enables non-invasive, scalable, and affordable neuro-biomarker monitoring. By targeting specific brain regions like the amygdala, clinicians can offer personalized treatments and optimize outcomes in mental healthcare, ushering in a transformative era for mental disorder care.